Your browser doesn't support javascript.
loading
Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk.
Azad, Arun A; Armstrong, Andrew J; Alcaraz, Antonio; Szmulewitz, Russell Z; Petrylak, Daniel P; Holzbeierlein, Jeffrey; Villers, Arnauld; Alekseev, Boris; Iguchi, Taro; Shore, Neal D; Gomez-Veiga, Francisco; Rosbrook, Brad; Lee, Ho-Jin; Haas, Gabriel P; Stenzl, Arnulf.
Afiliação
  • Azad AA; Monash Health, Melbourne, VIC, Australia.
  • Armstrong AJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
  • Alcaraz A; Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA. andrew.armstrong@duke.edu.
  • Szmulewitz RZ; Hospital Clinic de Barcelona, Barcelona, Spain.
  • Petrylak DP; The University of Chicago, Chicago, IL, USA.
  • Holzbeierlein J; Yale Cancer Center, New Haven, CT, USA.
  • Villers A; The University of Kansas Medical Center, Kansas City, KS, USA.
  • Alekseev B; Lille University, Lille, France.
  • Iguchi T; Hertzen Moscow Cancer Research Institute, Moscow, Russia.
  • Shore ND; Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Gomez-Veiga F; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
  • Rosbrook B; University Hospital, GITUR-IBSAL, University of Salamanca, Salamanca, Spain.
  • Lee HJ; Pfizer Inc., San Diego, CA, USA.
  • Haas GP; Astellas Pharma Inc., Northbrook, IL, USA.
  • Stenzl A; Astellas Pharma Inc., Northbrook, IL, USA.
Prostate Cancer Prostatic Dis ; 25(2): 274-282, 2022 02.
Article em En | MEDLINE | ID: mdl-34420037

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Benzamidas / Nitrilas Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Neoplasias da Próstata / Benzamidas / Nitrilas Idioma: En Ano de publicação: 2022 Tipo de documento: Article